Latest Orphan Drug Act Stories
SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
EPI-743 in phase 2B development for Leigh syndrome MOUNTAIN VIEW, Calif., June 9, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the FDA has granted Orphan Drug status
LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New Kauffman Foundation paper highlights solutions to speed patients’ access to drugs with therapeutic value for more than one disease. Kansas City, MO (PRWEB)
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Resolution Promotes Awareness of Rare Diseases Sacramento, CA (PRWEB) February 27, 2014 Today at the state Capitol, Assemblymember Kevin Mullin (D-South
EASTBOURNE, England, February 25, 2014 /PRNewswire/ -- Daval International, the emerging life sciences company focused on the development of novel treatments for serious
MarketReportsOnline.com adds "US Orphan Drug Market Outlook 2018" report to its research store. Dallas, Texas (PRWEB) February 14, 2014 In
NEW DELHI, February 7, 2014 /PRNewswire/ -- KuicK Research releases "Global Orphan Drug Market Outlook 2018" research report offering comprehensive insight on recent trends,
EPI-743 phase 2b Friedreich's ataxia trial fully enrolled. Downingtown, PA (PRWEB) February 04, 2014 Edison Pharmaceuticals today announced that
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.